<DOC>
	<DOCNO>NCT00045799</DOCNO>
	<brief_summary>Critically ill patient increase risk upper gastrointestinal ( GI ) bleed due stress relate mucosal damage . Cimetidine , deliver continuously intravenous infusion , drug FDA approve prevention upper GI bleed critically ill patient . The present trial intend assess safety efficacy omeprazole sodium bicarbonate immediate-release suspension indication .</brief_summary>
	<brief_title>Safety &amp; Efficacy Omeprazole Sodium Bicarbonate Prevention Upper GI Bleeding Critically Ill</brief_title>
	<detailed_description>This trial triple-blind , double-dummy , prospective , multicenter , randomize clinical trial compare effectiveness OSB-IR effectiveness intravenous cimetidine prevent upper GI bleeding risk SRMD .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Cimetidine</mesh_term>
	<criteria>Patients include trial meet follow criterion : 1 . An adult adolescent ( great equal 16 year age ) male nonpregnant female require mechanical ventilation great equal 48 hour . 2 . An anticipated ICU stay great equal 72 hour . 3 . An Acute Physiology Chronic Health Evaluation ( APACHE II ) score &gt; 11 immediately randomization . 4 . At least one risk factor upper GI bleeding due stressrelated mucosal damage addition mechanical ventilation . Acceptable `` '' risk factor include : closedhead injury multiple trauma head , chest , abdomen , solid organ , limb major surgical procedure ( eg , mastectomy , pancreatectomy , cardiovascular surgery ) 24 hour previous screen extensive burn ( great equal 30 % body surface area ) acute renal failure ( urine output &lt; 0.5 mL/kg body weight/hr one hour , despite adequate fluid resuscitation ) acidbase disorder ( pH less equal 7.3 base deficit great equal 5.0 mMol/L plasma lactate level &gt; 1.5 time upper limit normal report laboratory ) coagulopathy ( platelet count &lt; 50,000/mm3 , INR &gt; 1.5 [ i.e. , prothrombin time &gt; 1.5 time control value ] , partialthromboplastin time &gt; 2.0 time control value ) mark jaundice ( define plasma total bilirubin concentration &gt; 51.3 micromol/L &gt; 3 mg/dL ) coma hypotension ( either systolic blood pressure &lt; 80 mm Hg 2 hour decrease great equal 30 mm Hg systolic blood pressure ) shock ( arterial blood pressure less equal 90 mm Hg mean arterial pressure less equal 70 mm Hg least one hour despite adequate fluid resuscitation , adequate intravascular volume status use vasopressor attempt maintain systolic blood pressure great equal 90 mm Hg mean arterial pressure great equal 70 mm Hg ) sepsis ( define positively culture clinically diagnosed infection least three follow : body temperature great equal 38 degree C [ great equal 100.4 degree F ] less equal 36 degree C [ less equal 96.8 degree F ] , heart rate great equal 90 beats/min , tachypnea manifest respiratory rate great equal 20 breaths/min , hyperventilation indicate PaCO2 le equal 32 mm Hg , white blood cell count great equal 12,000 cells/mm3 less equal 4,000 cells/mm3 , presence &gt; 10 % band ) 5 . An intact stomach nasogastric orogastric tube place . 6 . An anticipation enteral feeding first two day trial drug treatment . Exclusion Criteria Patients exclude trial participation meet follow criterion : 1 . A status `` No Cardiopulmonary Resuscitation ( CPR ) '' . 2 . If &gt; 48 hour elapse since patient become eligible trial . 3 . Known history vagotomy , pyloroplasty , gastroplasty , gastric surgery . 4 . Known allergy cimetidine omeprazole . 5 . Active GI bleeding ( include esophageal gastric variceal bleeding , duodenal gastric ulcer ) . 6 . Significant risk swallow blood ( i.e. , severe facial trauma , oral laceration , hemoptysis ) . 7 . Enteral feeding first two day trial drug treatment . 8 . Use investigational drug within 30 day prior randomization . 9 . Critical/intensive care unit admission follow esophageal , gastric , duodenal surgery trauma . 10 . Known history upper gastrointestinal lesion likely bleed ( e.g. , esophageal gastric varix , gastric polyp , tumor , etc . exclude patient gastric duodenal ulcer disease ) . 11 . Any medical surgical condition precludes administration oral medication ( i.e. , OSBIR ) . 12 . End stage liver disease .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>